Rabies vaccine is associated with decreased all-cause mortality in dogs

Publication date: 5 July 2017
Source:Vaccine, Volume 35, Issue 31
Author(s): Darryn L. Knobel, Sintayehu Arega, Bjorn Reininghaus, Gregory J.G. Simpson, Bradford D. Gessner, Henrik Stryhn, Anne Conan
Evidence suggests that rabies vaccine may have non-specific protective effects in animals and children. We analyzed four years of data (2012–2015) from an observational study of the health and demographics of a population of owned, free-roaming dogs in a low-income community in South Africa. The objective of this analysis was to assess the association between rabies vaccine and all-cause mortality in dogs, stratified by age group (0–3months, 4–11months, and 12months and older), and controlling for the effects of sex and number of dogs in the residence. Rabies vaccination reduced the risk of death from any cause by 56% (95% CI=16–77%) in dogs aged 0–3months, by 44% (95% CI=21–60%) in dogs aged 4–11months and by 16% (95% CI=0–29%) in dogs aged 12months and older. We hypothesize that the protective association between rabies vaccination status and all-cause mortality is due to a protective effect of rabies vaccine against diseases other than rabies. Existence of a strong non-specific protective effect of rabies vaccine on mortality in dogs would have implications for the design of dog rabies control programs that aim to eliminate dog-mediated human rabies cases. Further, we propose that owned domestic dogs in high mortality settings provide a useful animal model to better understand any non-specific protective effect of rabies vaccine in children, due to dogs' high numbers, high morbidity and mortality rates, relatively short lifespan, exposure to a variety of infectious and parasitic diseases, and shared environment with people.



http://ift.tt/2slTrNS